本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ventyx Biosciences, Inc.

2.08
+0.06002.97%
盘后2.04-0.0400-1.92%16:42 EDT
成交量:87.36万
成交额:177.32万
市值:1.48亿
市盈率:-1.19
高:2.08
开:2.06
低:1.99
收:2.02
数据加载中...
2024/02/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/22

重要事件披露

Form 8-K - Current report
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities